Healthcare | April 28, 2026
Rheumatology Awareness Walkathon 2026 spotlights arthritis and autoimmune care
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
Rs. 40 cr buyback, 200% dividend announced
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
Subscribe To Our Newsletter & Stay Updated
